Cyon Therapeutics Inc

Cyon Therapeutics Inc. is a clinical phase biotechnology company with the goal to address the unmet medical need of severe infection and prevention of sepsis.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Vancouver, BC, Canada
  • Currency CAD
  • Founded February 2014
  • Employees 2
  • Incorporation Type C-corp
  • Website cyontherapeutics.com

Company Summary

Cyon Therapeutics Inc. is a clinical phase biotechnology company. Our goals is to address the unmet medical need of severe infection leading to sepsis. Cyon has licensed an anti-PCSK9 MAb from large pharma; worldwide rights for use severe infections and sepsis. Currently no therapeutic carries a Sepsis indication. The market potential for USA, Canada, Europe and Japan is $5B USD.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free